Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination drugs
Pharma
FDA signs off on Merck's HIV combo pill Idvynso
The once-daily HIV treatment regimen offers a new mechanism of action in the HIV treatment market.
Zoey Becker
Apr 21, 2026 3:26pm
Pfizer, Moderna and more look to combine COVID and flu markets
Jan 23, 2023 9:25am
Gilead trumpets a Biktarvy win in HIV, hepatitis B co-infection
Aug 1, 2022 10:17am
Bristol Myers' Opdivo in FDA fast lane for pre-surgery NSCLC
Feb 28, 2022 10:30am
Lenvima fails to improve on Keytruda—again
Feb 15, 2022 10:00am
Celltrion races inhaled COVID-19 antibody therapy into phase 3
Feb 7, 2022 7:30am
